Oncology Information Systems Market Share and Size 2034
Global Oncology Information Systems Market Size- By Products & Services, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Nov-2025 | Report ID: HLCA25332 | Pages: 1 - 269 | Formats*: |
| Category : Healthcare | |||
Global Oncology Information Systems Market Introduction and Overview
According to SPER Market Research, the Global Oncology Information Systems Market is estimated to reach USD 2.13 billion by 2034 with a CAGR of 4.98%.
The report includes an in-depth analysis of the Global Oncology Information Systems Market, including market size and trends, product mix, Applications, and supplier analysis. The global Oncology Information Systems market was valued at USD 1.31 billion in 2024, and it is expected to rise at a 4.98% CAGR from 2025 to 2034. The growing adoption of advanced technologies, such as artificial intelligence and cloud-based platforms, enables more accurate diagnosis, treatment personalization, and streamlined workflows. Increasing integration of OIS with electronic health records (EHR) and radiotherapy equipment enhances operational efficiency and data management in hospitals and cancer care centres.
Additionally, the shift toward value-based care and precision oncology emphasizes the need for comprehensive systems that improve patient outcomes and reduce treatment errors. Expanding healthcare infrastructure, rising healthcare spending, and supportive government initiatives further boost market growth.
By Products & Services Insights
The solutions segment dominates the Oncology Information Systems (OIS) market, driven by software that maintains patient records, predicts treatment outcomes, and plans cancer treatment regimens. These solutions facilitate seamless information exchange across healthcare organizations, bridging practitioners and radiology centres, which enhances the safety and efficiency of cancer care. They also assist physicians and surgeons in selecting appropriate treatments, improving patient survival rates.
By Application Insights
The medical oncology segment leads the Oncology Information Systems (OIS) market, driven by its use of immunotherapy, chemotherapy, hormonal therapy, and targeted therapy, offering a comprehensive and effective approach to cancer treatment. The rising prevalence of cancer and increased adoption of these therapies are key factors fuelling market growth. Meanwhile, the surgical oncology segment is also expected to grow significantly, as cancer treatment increasingly combines surgery with multi-modal therapies such as radiotherapy, targeted molecular treatments, and chemotherapy. The growing complexity of surgical procedures and the need for multidisciplinary coordination among specialists drive the adoption of OIS in surgical oncology, supporting efficient treatment planning, communication, and improved patient outcomes.
By End-User Insights
The hospitals and diagnostic imaging centres segment dominate the Oncology Information Systems (OIS) market, as these facilities adopt OIS to streamline workflows, integrate multidisciplinary data, and enhance cancer treatment planning. By connecting oncologists, radiologists, and pathologists, OIS enables comprehensive patient data management, reduces errors, and improves operational efficiency. Integration with electronic health records (EHRs) minimizes redundant testing and optimizes resource utilization. As hospitals expand radiation oncology services and seek cost-effective cancer care solutions, demand for OIS continues to grow. Meanwhile, ablation and cancer care centres are expected to register the fastest growth, leveraging OIS to integrate real-time imaging, ablation devices, and patient data for precise tumour targeting, improving procedural accuracy and treatment outcomes.
Regional Insights
North America leads the Oncology Information Systems (OIS) market, holding the largest revenue share in 2024. The region’s adoption is driven by the growing need for efficient, precise, and advanced cancer treatment and care solutions. Factors supporting this growth include well-developed healthcare infrastructure, the presence of leading cancer research institutions, substantial healthcare spending, high patient disposable incomes, and a strong reimbursement framework. These elements collectively facilitate the widespread implementation of OIS, enabling hospitals and cancer care centres to streamline workflows, integrate multidisciplinary data, and improve treatment planning and patient outcomes, solidifying North America’s dominant position in the global market.
Market Competitive Landscape
The Oncology Information Systems (OIS) market, competition is intense among leading companies such as Elekta AB, Varian Medical System, RaySearch Laboratories, Accuray Incorporated, Cerner Corporation, Philips Healthcare, Flatiron Health, and BrainLab. These firms compete primarily on technological innovation, product portfolio breadth, and integration capabilities.
Companies like Varian and Elekta focus on advanced radiotherapy planning and precision oncology solutions, while RaySearch Laboratories and BrainLab emphasize workflow automation and software interoperability. Philips, Cerner, and Oracle compete on hospital-wide integration, cloud-based solutions, and electronic health record (EHR) connectivity. Other factors influencing competition include pricing strategies, regulatory compliance, global presence, customer support, and strategic partnerships or acquisitions aimed at expanding market share and entering emerging regions.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Products & Services, By Application, By End User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Accuray Incorporated, BrainLab, DOSIsoft SA, Elekta, FLATIRON HEALTH, Koninklijke Philips N.V, Oracle (Cerner Corporation), RaySearch Laboratories, Varian Medical Systems, Inc. |
Key Topics Covered in the Report
- Global Oncology Information Systems Market Size (FY’2021-FY’2034)
- Overview of Global Oncology Information Systems Market
- Segmentation of Global Oncology Information Systems Market By Products & Services (Software, Services)
- Segmentation of Global Oncology Information Systems Market By Application (Medical Oncology, Radiation Oncology, Surgical Oncology)
- Segmentation of Global Oncology Information Systems Market By End-user (Hospitals & Diagnostic Imaging Centres, Ablation Care Centres and Cancer Care Centres, Research Facilities)
- Statistical Snap of Global Oncology Information Systems Market
- Expansion Analysis of Global Oncology Information Systems Market
- Problems and Obstacles in Global Oncology Information Systems Market
- Competitive Landscape in the Global Oncology Information Systems Market
- Details on Current Investment in Global Oncology Information Systems Market
- Competitive Analysis of Global Oncology Information Systems Market
- Prominent Players in the Global Oncology Information Systems Market
- SWOT Analysis of Global Oncology Information Systems Market
- Global Oncology Information Systems Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Oncology Information Systems Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Oncology Information Systems Market
7.Global Oncology Information Systems Market, By Products & Services (USD Million) 2021-2034
7.1.Software7.1.1.Treatment Planning Systems7.1.2.Patient Information Systems7.2.Services
8.Global Oncology Information Systems Market, By Application (Medical Oncology) (USD Million) 2021-2034
8.1.Medical Oncology8.2.Radiation Oncology8.3.Surgical Oncology
9.Global Oncology Information Systems Market, By End-User (USD Million) 2021-2034
9.1.Hospitals & Diagnostic Imaging Centres9.2.Ablation Care Centres and Cancer Care Centres9.3.Research Facilities
10.Global Oncology Information Systems Market, (USD Million) 2021-2034
10.1.Global Oncology Information Systems Market Size and Market Share
11.Global Oncology Information Systems Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific
11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada11.4.2.Mexico11.4.3.United States
11.5.Latin America
11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1.Accuray Incorporated
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2.BrainLab
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3.DOSIsoft SA
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4.Elekta
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5.FLATIRON HEALTH
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6.Koninklijke Philips N.V
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7.Oracle (Cerner Corporation)
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8.RaySearch Laboratories
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9.Varian Medical Systems, Inc
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Oncology Information Systems Market is projected to reach USD 2.13 billion by 2034, growing at a CAGR of 4.98% during the forecast period.
Oncology Information Systems Market size from 2025. The Market is expected to reach USD 2.13 billion by 2034, at a CAGR of 4.98% during the forecast period.
Oncology Information Systems Market CAGR of 4.98% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Oncology Information Systems Market size is USD 2.13 billion from 2025 to 2034.
Oncology Information Systems Market covered By Products & Services, By Application, By End User
The North America is anticipated to have the highest Market share in the Oncology Information Systems Market.
Accuray Incorporated, BrainLab, DOSIsoft SA, Elekta, FLATIRON HEALTH, Koninklijke Philips N.V, Oracle (Cerner Corporation), RaySearch Laboratories, Varian Medical Systems, Inc.
The report includes an in-depth analysis of the Global Oncology Information Systems Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
